Two Brain & Behavior Research Foundation Scientific Council Members have announced promising results of clinical trials of a ketamine-alternative called BCI-838 for the treatment of depression. Ketamine works within...
Next Generation Therapies
Fred H. Gage, Ph.D.
July 24, 2012
Olivier Berton, Ph.D.
June 29, 2012
Elevated levels of a class of hormones called glucocorticoids have long been linked to anxiety disorders and depression. It is known that the presence of too much of these hormones mediates what we call ‘stress’ and that...
Richard Keefe, Ph.D.
June 28, 2012
Brain & Behavior Research Foundation Scientific Council Member Richard Keefe, Ph.D., Director of the Schizophrenia Research Group at the Duke Institute for Brain Sciences, is one of the leaders of a multi-center...
James F. Leckman, M.D.
May 25, 2012
NARSAD Distinguished Investigator Grantee, James F. Leckman, M.D., professor of Pediatrics and Psychiatry at the Yale University Child Study Center, is one of the researchers talking part in an ongoing, large-scale study...
HDAC6
May 01, 2012
Two-time NARSAD Young Investigator Grantee, Olivier Berton, Ph.D., assistant professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania and a team of researchers have shown that the...
Pages
